Evidence map›Paper›PMID 40438810›Full record

ArticleCureus2025

One-Year Results of Orthokeratology and Defocus Incorporated Multiple Segment Lenses in French Children for Myopia Control.

Florent Boulanger, Julien Poret, Pan Liu, Benjamin Jany, Emmanuel Bui Quoc, Thi Ha Chau Tran

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Florent BoulangerOphthalmology, Amiens University Hospital, Amiens, FRA.
Julien PoretOphthalmology, Amiens University Hospital, Amiens, FRA.
Pan LiuMedical Image Processing, Amiens University Hospital, Amiens, FRA.
Benjamin JanyOphthalmology, Amiens University Hospital, Amiens, FRA.
Emmanuel Bui QuocOphthalmology, Robert Debre University Hospital, Paris, FRA.
Thi Ha Chau TranOphthalmology, Amiens University Hospital, Amiens, FRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose Myopia is a common refractive error affecting vision. This study aims to evaluate two real-world methods for myopia control: orthokeratology (ortho-k) and defocus incorporated multiple segment (DIMS) spectacles lenses. Methods This retrospective observational multicenter study was conducted on a French population with myopia, treated with either DIMS spectacle lenses or ortho-k for myopia control. Baseline axial length (AL) and spherical equivalent refraction (SER) were recorded, along with data at six and 12 months. AL change was used as the primary criterion for myopia control. Results We included 111 patients in the ortho-k group and 88 in the spectacle lenses group. The mean baseline AL was 24.46 mm in the spectacle lenses group and 25.05 mm in the ortho-k group. No significant difference in AL elongation was observed between the two groups at the six- and 12-month time points. At six months, SER change in the DIMS group was significantly lower than in the ortho-k group; however, this difference was not maintained at 12 months. The mean AL elongation at 12 months was 0.12 mm (n=162) in the ortho-K group vs. 0.16 mm in the DIMS group (n=70). Conclusion The study provides new real-world data on myopia control techniques in French children. Both techniques appear to yield similar results over a one-year period.

Indexed as

axial lengthdefocus incorporated multiple segmentshighly aspheric lensmyopiamyopia controlorthokeratology

Identifiers

PMID40438810
PMCPMC12117353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.